Algo version: 0.98b
CLGN is listed at the NASDAQ Exchange
CLGN [CLGN]
NASDAQ Sector: Healthcare Industry:Biotechnology

Is CLGN stock a buy?

What Is The Conclusion?

Right now our advanced algorithms say:

Do the analyst corps agree?

Interesting Questions and Easy Answers!

We cannot find any recorded dividends paid in our systems.

Sorry, we do not have any analyst data for this ticker

We cannot find data for Collplant Biotechnologies 10 years ago, but if you had invested on Tuesday 30th of January 2018 when the price was $9.00, you would have made a loss of $-3.90 per share or -43.33%

No, the average daily trading liquidity for Collplant Biotechnologies is $51 793 thousand. Trading in stocks with this little trading liquidity is very dangerous, and you can get into a situation where it will be hard to trade your stocks. In addition, these types of stocks usually have very high volatility.

Collplant Biotechnologies has little of the business financed by loans. This puts the company at lower risk in periods of high inflation where borrowing costs usually go up. The company is still not profitable, and high inflation will make it harder to become profitable as costs increase and consumer spending decreases.

We have calculated the inflation risk for Collplant Biotechnologies to be medium [0.7 out of 1]